Abstract:Insulin is a protein hormone secreted by pancreatic,6 cells. One of its main functions is to keep the balance of glucose inside the body by regulating the absorption and metabolism of glucose in the periphery tissue, as well as the production and storage of hepatic glycogen. The insulin receptor is a transmembrane glycoprotein in which two a subunits with a molecular weight of 135 kD and two beta subunits with a molecular weight of 95 kD are joined by a disulfide bond to form a beta-alpha-alpha-beta structure. The extracellular a subunit, especially, its three domains near the N-terminal are partially responsible for signal transduction or ligand-binding, as indicated by the experiments. The extracellular a subunits are involved in binding the ligands. The experimental results indicate that the three domains of the N-terminal of the a subunits are the main determinative parts of the insulin receptor to bind the insulin or mimetic peptide. We employed the extracellular domain(PDBID: 11GR) of the insulin-like growth factor-1 receptor(IGF-1R) as the template to simulate and optimize the spatial structures of the three domains in the extracellular domain of the insulin receptor, which includes 468 residues. The work was accomplished by making use of the homology program in the Insight U package on an Origin3800 server. The docking calculations of the insulin receptor obtained by homology with hexapeptides were carried out by means of the program Affinity. The analysis indicated that there were hydrogen bonding, and electrostatic and hydrophobic effects in the docking complex of the insulin receptor with hexapeptides. Moreover, we described the spatial orientation of a mimetic peptide with agonist activity in the docking complex. We obtained a rough model of binding of DLAPSQ or STIVYS with the insulin receptor, which provides the powerful theoretical support for designing the minimal insulin mimetic peptide with agonist activity, making it possible to develop oral small molecular hypoglycemic drugs.

Hydroxyl Group of Insulin A19Tyr is Essential for Receptor Binding: Studies on (a19phe) Insulin

Efects of Deleting A19 Tyrosine Form Insulin

The A-chain of Insulin Contacts the Insert Domain of the Insulin Receptor

Insulin and Its Single-Chain Analogue

Characteristic, Activity and Conformational Studies of [A6-Ser, A11-Ser]-insulin.

Effects of Deletion and Shift of the A20-B19 Disulfide Bond on the Structure, Activity, and Refolding of Proinsulin.

Intra-A Chain Disulfide Bond (A6-11) of Insulin is Essential for Displaying Its Activity

How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.

How Insulin Binds: the B-Chain α-Helix Contacts the L1 β-Helix of the Insulin Receptor

Diabetes-associated Mutations in Insulin: Consecutive Residues in the B Chain Contact Distinct Domains of the Insulin Receptor.

Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues.

Contribution of TyrB26 to the Function and Stability of Insulin: STRUCTURE-ACTIVITY RELATIONSHIPS AT A CONSERVED HORMONE-RECEPTOR INTERFACE

Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama

The Structure of a Mutant Insulin Uncouples Receptor Binding from Protein Allostery. an Electrostatic Block to the TR Transition.

Structural Resolution Of A Tandem Hormone-Binding Element In The Insulin Receptor And Its Implications For Design Of Peptide Agonists

Crystallographic Study on Highly Stable Human Insulins(Ii) - Crystallization and Preliminary Crystallographic Study of A21-Gly Mutant

Purification and Characterization of B_23-Gly-B_24 Human Insulin

Identification of the Nitration Site of Insulin by Peroxynitrite.

Binding Mode of Insulin Receptor and Agonist Peptide

Hyperinsulinaemic Hypoglycaemia Associated With A Heterozygous Missense Mutation Of R1174w In The Insulin Receptor (Ir) Gene

How Insulin Binds to the Insulin Receptor: A Synthetic Chemical Biology Approach